Return to Article Details CRISPR-CAS THERAPEUTICS AGAINST EXTENSIVELY DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS: OPPORTUNITIES FOR PRECISION ANTIMICROBIAL INTERVENTION Download Download PDF